Startup | May 09, 2022
InxMed raises US $ 15 million in Series B+ financing
The plan is to advance innovative therapies to drug-resistant cancers
The plan is to advance innovative therapies to drug-resistant cancers
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
He will be leading the business, operations, P&L, and growth strategy for StanPlus
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
Subscribe To Our Newsletter & Stay Updated
